Tourette Syndrome News and Research

RSS
Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. The disorder is named for Dr. Georges Gilles de la Tourette, the pioneering French neurologist who in 1885 first described the condition in an 86-year-old French noblewoman.

The early symptoms of TS are almost always noticed first in childhood, with the average onset between the ages of 7 and 10 years. TS occurs in people from all ethnic groups; males are affected about three to four times more often than females. It is estimated that 200,000 Americans have the most severe form of TS, and as many as one in 100 exhibit milder and less complex symptoms such as chronic motor or vocal tics or transient tics of childhood. Although TS can be a chronic condition with symptoms lasting a lifetime, most people with the condition experience their worst symptoms in their early teens, with improvement occurring in the late teens and continuing into adulthood.
First self-assessment test developed to help clinicians diagnose autism in adults

First self-assessment test developed to help clinicians diagnose autism in adults

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

Neurocrine reports net loss of $1.2 million for first quarter 2015

Neurocrine reports net loss of $1.2 million for first quarter 2015

Tourette syndrome patients may face second psychiatric disorder during their lifetimes

Tourette syndrome patients may face second psychiatric disorder during their lifetimes

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

AAN urges for more research on use of medical marijuana for brain, nervous system disorders

AAN urges for more research on use of medical marijuana for brain, nervous system disorders

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Teen binge drinking effects may last a lifetime, suggests UMass Amherst study

Teen binge drinking effects may last a lifetime, suggests UMass Amherst study

Intensive parenting and education provided in homes reduces drug use in pregnant teens

Intensive parenting and education provided in homes reduces drug use in pregnant teens

Identification of neurotransmitter imbalance in Tourette Syndrome offers new treatment hope

Identification of neurotransmitter imbalance in Tourette Syndrome offers new treatment hope

Scientists develop algorithm to uncover genomic insertions and deletions involved in autism, OCD

Scientists develop algorithm to uncover genomic insertions and deletions involved in autism, OCD

AAN review finds certain forms of medical marijuana can help treat some symptoms of MS

AAN review finds certain forms of medical marijuana can help treat some symptoms of MS

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Study raises hopes for new drugs to treat brain disorders associated with neurotransmitter imbalance

Study raises hopes for new drugs to treat brain disorders associated with neurotransmitter imbalance

Chinese herbal medicine effective at alleviating acute inflammatory and nerve pain

Chinese herbal medicine effective at alleviating acute inflammatory and nerve pain

Researchers discover new mechanism in brain which controls tics in children with TS

Researchers discover new mechanism in brain which controls tics in children with TS

Study explores social and emotional impact of Tourette syndrome in secondary schools

Study explores social and emotional impact of Tourette syndrome in secondary schools

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Obsessive-compulsive disorder and Tourette syndrome are highly heritable

Obsessive-compulsive disorder and Tourette syndrome are highly heritable

Inner-ear dysfunction can increase hyperactivity, say researchers

Inner-ear dysfunction can increase hyperactivity, say researchers